The Management of Incidental Prostate Cancer Following TURP

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Transurethral resection of the prostate (TURP) is a common procedure for benign prostatic hyperplasia.
• Incidental prostate cancer (CaP) can be diagnosed following TURP, necessitating evaluation of its management and outcomes.

Purpose of the Study:

• To determine the incidence of incidentally diagnosed prostate cancer (CaP) after TURP.
• To analyze the management strategies and patient outcomes for incidental CaP.
• To provide evidence-based recommendations for managing incidental CaP discovered during TURP.

Main Methods:

• Retrospective review of histopathological records from two university teaching hospitals.
• Analysis of data from 826 patients who underwent TURP over a ten-year period.
• Assessment of CaP diagnosis, management (expectant vs. active treatment), and mortality.

Main Results:

• An incidence of 10.3% (72 out of 826) for incidental CaP was observed post-TURP.
• 63.9% of patients with incidental CaP were managed expectantly, while 36.1% received active treatment.
• Overall mortality was 29.2%, with cancer-specific mortality at 6.9% (all in the hormonal treatment group).

Conclusions:

• An expectant management strategy is favorable for low-risk incidental prostate cancer.
• Curative treatment should be considered for younger patients with longer life expectancy or those with higher-risk disease.
• This study highlights the importance of careful follow-up and tailored management for incidental CaP post-TURP.